Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49.9M
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
49.2M
-
Shares change
-
+1.34M
-
Total reported value, excl. options
-
$1.79B
-
Value change
-
+$50.9M
-
Put/Call ratio
-
5.4
-
Number of buys
-
57
-
Number of sells
-
-62
-
Price
-
$36.33
Significant Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q3 2025
156 filings reported holding IMCR - Immunocore Holdings plc - Ordinary shares as of Q3 2025.
Immunocore Holdings plc - Ordinary shares (IMCR) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.2M shares
of 49.9M outstanding shares and own 98.47% of the company stock.
Largest 10 shareholders include T. Rowe Price Investment Management, Inc. (7.06M shares), RTW INVESTMENTS, LP (4.87M shares), WELLINGTON MANAGEMENT GROUP LLP (4.78M shares), FMR LLC (4.42M shares), PRIMECAP MANAGEMENT CO/CA/ (3.75M shares), Bellevue Group AG (2.8M shares), BAKER BROS. ADVISORS LP (2.32M shares), TANG CAPITAL MANAGEMENT LLC (2.31M shares), Deep Track Capital, LP (1.8M shares), and BVF INC/IL (1.57M shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.